MELANIE KNIGHT: Open Payments
NPI 1386835718 · MERRIAM, KS. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$404 in 17 payments from 12 companies in 2025. Trend: 2023 $360 · 2024 $182 · 2025 $404
Food & beverage: $404
| Company | Payments | Amount |
|---|---|---|
| Myriad Genetic Laboratories, Inc. | 1 | $96 |
| Merck Sharp & Dohme LLC | 3 | $63 |
| Novartis Pharmaceuticals Corporation | 3 | $50 |
| PFIZER INC. | 2 | $40 |
| Geron Corporation | 1 | $25 |
| Exelixis Inc. | 1 | $20 |
| ABBVIE INC. | 1 | $20 |
| Ipsen Biopharmaceuticals, Inc | 1 | $20 |
| AstraZeneca Pharmaceuticals LP | 1 | $18 |
| Incyte Corporation | 1 | $18 |
Products named: MYRISK, KEYTRUDA, PADCEV, KISQALI, RYTELO, SCEMBLIX, CABOMETYX, ELAHERE.
Industry payments across KS — which companies pay providers there.
